Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1201787-06-5

Post Buying Request

1201787-06-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1201787-06-5 Usage

Description

(1S,3R)-3-Aminomethyl-cyclopentanol is a chiral organic compound with the molecular formula C6H13NO. It is a cyclopentane derivative featuring an amino group and a hydroxyl group attached to adjacent carbon atoms. (1S,3R)-3-Aminomethyl-cyclopentanol is known for its two enantiomers, (1S,3R) and (1R,3S), which exhibit distinct biological activities and pharmacological properties. Its unique structure and chirality make it a valuable building block in the synthesis of pharmaceuticals and other biologically active molecules, with potential applications in medicinal chemistry, especially for the development of drugs targeting neurological disorders and other conditions.

Uses

Used in Pharmaceutical Synthesis:
(1S,3R)-3-Aminomethyl-cyclopentanol serves as a key building block in the creation of various pharmaceuticals. Its unique structure allows for the development of molecules with specific biological activities, making it a crucial component in medicinal chemistry.
Used in Medicinal Chemistry Research:
(1S,3R)-3-Aminomethyl-cyclopentanol is utilized in medicinal chemistry for the exploration and development of new drugs. Its chiral nature provides a platform for studying the effects of different enantiomers on biological systems, which is vital for understanding their therapeutic potential and optimizing drug design.
Used in the Development of Neurological Disorder Treatments:
(1S,3R)-3-Aminomethyl-cyclopentanol has potential applications in the development of treatments for neurological disorders. Its ability to be incorporated into biologically active molecules makes it a promising candidate for creating drugs that can target and treat such conditions.
Used in Biologically Active Molecule Synthesis:
Beyond pharmaceuticals, (1S,3R)-3-Aminomethyl-cyclopentanol is also used in the synthesis of other biologically active molecules. Its versatility in molecular construction allows for the creation of compounds with a range of applications in the life sciences.

Check Digit Verification of cas no

The CAS Registry Mumber 1201787-06-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,0,1,7,8 and 7 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1201787-06:
(9*1)+(8*2)+(7*0)+(6*1)+(5*7)+(4*8)+(3*7)+(2*0)+(1*6)=125
125 % 10 = 5
So 1201787-06-5 is a valid CAS Registry Number.

1201787-06-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name (1S,3R)-3-Aminomethyl-cyclopentanol

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1201787-06-5 SDS

1201787-06-5Relevant articles and documents

POLYFLUORINATED COMPOUNDS ACTING AS BRUTON TYROSINE KINASE INHIBITORS

-

Paragraph 0391; 0392, (2016/08/17)

Described herein is a novel series of multi-fluoro-substituted pyrazolopyrimidine compounds or salts thereof. These compounds are Bruton's tyrosine kinase (BTK) inhibitors. These compounds may possess better BTK inhibition selectivity and pharmacokinetic properties. Disclosed herein are the synthesis methods of these compounds. Disclosed herein are novel synthesis methods of the multi-fluoro-substituted benzophenone and substituted phenoxy benzene. Also disclosed are pharmaceutical compositions comprising the BTK inhibitors described herein. The present invention also relates to pharmaceutical formulations comprising the compounds described herein as active ingredients. The present invention also includes the therapeutic methods by administering the BTK inhibitors and their formulations to treat and inhibit autoimmune disease, hypersensitivity disease, inflammatory diseases and cancer.

Cycloalkyl-one-containing benzenesulphonamides

-

, (2008/06/13)

Cycloalkanol[1,2-b]indole-sulphonamides of the formula STR1 where appropriate in an isomeric form, and their salts are disclosed. These compounds are useful to inhibit platelet aggregation and to antagonize thromboxane A2.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1201787-06-5